Bio Essence Corporation
BIOE
$0.0937
$0.00272.97%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 521.34% | -- | 171.96% | -13.49% | -83.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 521.34% | -- | 171.96% | -13.49% | -83.94% |
| Cost of Revenue | 624.00% | -- | -- | -60.37% | -91.66% |
| Gross Profit | 477.40% | -- | -- | 300.99% | -73.38% |
| SG&A Expenses | -44.70% | 48.68% | 126.93% | -38.11% | -42.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.26% | 49.74% | 121.52% | -44.09% | -57.50% |
| Operating Income | 137.09% | -35.11% | -98.46% | 57.82% | 27.22% |
| Income Before Tax | 128.25% | -67.32% | -112.77% | -281.04% | 23.60% |
| Income Tax Expenses | 0.00% | -- | 100.00% | -- | -75.00% |
| Earnings from Continuing Operations | 127.77% | -67.32% | -112.67% | -281.04% | 24.18% |
| Earnings from Discontinued Operations | -- | -- | 100.00% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 127.77% | -253.70% | 85.75% | -281.04% | 24.18% |
| EBIT | 137.09% | -35.11% | -98.46% | 57.82% | 27.22% |
| EBITDA | 137.22% | -35.49% | -98.16% | 55.74% | 21.76% |
| EPS Basic | 128.07% | -254.29% | 89.23% | -280.72% | 30.49% |
| Normalized Basic EPS | 128.57% | -70.00% | -120.00% | 42.86% | 31.37% |
| EPS Diluted | 128.07% | -254.29% | 89.23% | -280.72% | 30.49% |
| Normalized Diluted EPS | 128.57% | -70.00% | -120.00% | 42.86% | 31.37% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 11.94% | 0.00% | 9.50% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 11.94% | 0.00% | 9.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |